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ABSTRACT
The ability to perform molecular-level computation
in mammalian cells has the potential to enable a
new wave of sophisticated cell-based therapies
and diagnostics. To this end, we developed a
Boolean logic framework utilizing artificial Cys2–
His2 zinc finger transcription factors (ZF-TFs) as
computing elements. Artificial ZFs can be
designed to specifically bind different DNA se-
quences and thus comprise a diverse set of com-
ponents ideal for the construction of scalable
networks. We generate ZF-TF activators and repres-
sors and demonstrate a novel, general method to
tune ZF-TF response by fusing ZF-TFs to leucine
zipper homodimerization domains. We describe 15
transcriptional activators that display 2- to 463-fold
induction and 15 transcriptional repressors that
show 1.3- to 16-fold repression. Using these
ZF-TFs, we compute OR, NOR, AND and NAND
logic, employing hybrid promoters and split intein-
mediated protein splicing to integrate signals. The
split intein strategy is able to fully reconstitute the
ZF-TFs, maintaining them as a uniform set of
computing elements. Together, these components
comprise a robust platform for building mammalian
synthetic gene circuits capable of precisely
modulating cellular behavior.
INTRODUCTION
Mammalian synthetic gene circuits have the potential to
directly impact human health in applications such as cell-
and animal-based disease models, gene therapies and
smart therapeutics. Signiﬁcant progress has been made
to generate such networks, including: RNAi-based
systems to interrogate siRNAs, microRNAs and synthetic
transcription factors, RNA aptamer systems to sense
multiple small molecules and metabolites and transcrip-
tion factor-based systems to sense synthetic small mol-
ecules (1–6). However, despite the efﬁcacy of these
systems several engineering challenges remain. The
majority of published systems rely on the use of a small
set of specialized factors such as LacI, Gal4 and TetR and
are not amenable to the design of large-scale networks.
Methods to tune system responses over a wide dynamic
range are lacking and are often speciﬁc to specialized
system components. Finally, many signal integration
strategies are limited by their input modularity and are
not amenable to the facile generation of different types
of logic gates. In this work, we address these issues by
developing a computational platform consisting of Cys2–
His2 zinc ﬁnger transcription factors (ZF-TF) computing
elements, general strategies to tune these ZF-TFs and
general strategies to integrate transcriptional input signals.
Cys2–His2 ZFs are small protein domains sharing a
common zinc atom coordinating structural motif, many
of which are capable of binding to speciﬁc DNA sequences
with high afﬁnities. Recent advances in the ability to
engineer ZF DNA binding domains (DBDs) to recognize
new nucleotide sequences have made them a rich potential
source of independently functioning system components
(7,8). As most artiﬁcial ZFs are constructed from a
single canonical ZF, Zif268, they are also similar in
amino acid composition and structure and are likely to
share similar biological properties. In our systems, we
use a set of ﬁve previously developed ZF DBDs that
target three orthogonal 9bp DNA sequences with high
speciﬁcity: BCR_ABL-1, BCR_ABL-2, erbB2, HIV-1
and HIV-2 (9).
Because biological signals vary greatly in strength and
composition, it is desirable to have a set of tunable
computing elements to interrogate these signals. A
common cellular strategy to modulate TF activity is
through cooperative binding between TFs, a process
often mediated by leucine zipper (LZ) protein–protein
interaction domains (10). Whereas the effect of LZs on
the structure and function of ZF DBDs has been
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ZF-TF activity in cells has not been explored (11–13).
We chose two well-characterized homodimerizing LZ
domains with different binding afﬁnities, the protein
interaction domains of human c-Jun (Kd=448mM) and
Saccharomyces cerevisiae GCN4 (Kd=8nM), to tune
our engineered ZF-TFs (14,15). We combine and
compare this new tuning strategy to a previously shown
method to modulate TF activity, altering the number of
binding sites in ZF response promoters, further increasing
the range of system tunability.
To date, relatively few transcriptional logic gates have
been demonstrated, and gates have largely been pursued
outside the context of a general computational frame-
work. To compute OR and NOR logic using transcrip-
tional networks, previous researchers have used hybrid
transcription factor response promoters containing
binding sites for multiple TFs (1). We demonstrate that
it is also possible to create and tune ZF-TF-based OR and
NOR gates using this architecture. Previous efforts to
create individual AND gates have relied on the association
of split TF fragments in two-hybrid systems, potentially
limiting the activation strength of these systems and scal-
ability (6). To our knowledge, a NAND gate has not been
constructed using split transcription factors in mammalian
cells.
We chose to pursue split intein-mediated protein
splicing as an attractive alternative approach to perform
both AND and NAND computations. Split inteins, when
fused to separate protein fragments, auto-catalytically
splice the two fragments into a single protein without
leaving a peptide scar. They have been shown to
function at high efﬁciency in mammalian cells and in a
wide range of proteins, and over 500 inteins have been
discovered to date (16–18). We chose to use the dnaB
mini-intein from Rhodothermus marinus as it has been pre-
viously demonstrated to display 100% splicing efﬁciency
in mammalian cells (16). Utilizing this protein splicing
strategy we can reconstitute ZF-TFs for AND and
NAND gates allowing logic computations to be enacted
by complete factors, potentially yielding stronger and
more uniform system responses.
MATERIALS AND METHODS
Recombinant DNA constructs
Constructs encoding ZF DBDs were codon-optimized for
mammalian expression and synthesized (Genscript). The
rma intein fragments and the GCN4 leucine zipper se-
quences were codon optimized for mammalian expression
and synthesized (Integrated DNA Technologies). Intein-
ZF fusion parts were cloned using PCR and BbsI Type-IIS
restriction enzyme methods. All experimental DNA con-
structs were generated by combining BioBrick subparts
using Biobrick assembly (19,20). Each ﬁnal construct
and its constituent Biobrick subparts is listed in
Supplementary Table S1. Sequences of all Biobrick
subparts are listed in Supplementary Table S2. For expres-
sion constructs, coding regions cut with XbaI and
NotI were cloned into the NheI and NotI sites of a
modiﬁed version of pCDNA5/FRT/TO (Invitrogen),
‘pCDNA5insVector’. pCDNA5insVector was generated
by cloning the subpart ‘pCDNA5ins’ between the two
PmeI sites of pCDNA5/FRT/TO. All reporter constructs
were cut with SpeI and NotI and cloned between the SpeI
and NotI sites of pCDNA5/FRT/TO.
Cell culture
The human osteosarcoma-derived epithelial cell line U-2
OS (ATCC no. HTB-96) was maintained at 37C, 5%
CO2 in growth medium (McCoy’s 5A medium supple-
mented with 10% FBS, 2mM L-glutamine, 100U/ml
penicillin and 100mg/ml streptomycin). A summary of
the plasmid amounts used for transfections can be found
in Supplementary Table S1. All transfections were per-
formed in 12-well plates seeded with 150000 cells using
3ml Lipofectamine LTX transfection reagent and 1ml
PLUS reagent (Invitrogen) with 1mg total DNA per well
in 1ml of growth medium. Transfection reagent was
washed out and replaced with fresh growth media 6h
post-transfection.
Microscopy
Microscopy was performed on live cells in glass-bottomed
wells (MatTek) in phenol red-free growth medium 48h
post-transfection. Cells were imaged by a Nikon
TE-2000 microscope with a 20 PlanFluor NA=0.5,
DIC M/N2 objective and an ORCA-ER charge-coupled
device camera. Data collection and processing were per-
formed using Metamorph 7.0 software (Molecular
Devices). All images within a given experimental set
were collected using the same exposure times, averaged
over three frames and underwent identical processing.
Flow cytometry
Approximately 30000 live cells from each transfected well
were analyzed using an LSRII cell analyser (BD
Biosciences) in three biological replicates. Cells were
trypsinized with 0.1ml of 0.25% trypsin–EDTA, pelleted
and resuspended in 100ml of Dulbecco’s phosphate
buffered saline containing 0.1% FBS. Output was
assayed 48h post-transfection. First, the total AmCyan
ﬂuorescent protein (CFP) signal of mCh+ cells was
calculated by multiplying the frequency of CFP+cells in
the mCH+ population by the mean CFP signal of these
double positive cells. Fold change was calculated by
dividing the total CFP of mCH+ experimental cells by
the total CFP values of mCH+ off-target control cells.
An example of the raw data and gating procedure is
given in Supplementary Figure S3. Values were averaged
over three replicates and standard deviations were
determined. In assays containing multiple off-target ex-
periments, fold changes were calculated using the
average of all off-target control wells to compare the back-
ground leakiness of the different reporter constructs. Total
CFP values and standard deviations for all experiments
are listed in Supplementary Table S4.
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Tuning ZF-TFs
We ﬁrst generated a set of 15 ZF transcriptional activators
and demonstrated the ability to increase their activity with
increasing LZ strength. Each activator was comprised of a
ZF DBD, either no LZ motif, a Jun LZ, or a GCN4 LZ,
the transcriptional activation domain VP64 and the SV40
nuclear localization signal (NLS). Activators were ex-
pressed from the CMV promoter and tagged with
co-translationally cleaved t2a:mCherry to monitor expres-
sion (Figure 1A) (21). We assayed activator function by
co-transfection with reporter plasmids containing differ-
ent numbers of ZF binding sites driving expression of
AmCyan ﬂuorescent protein CFP (Figure 1A). We ﬁrst
tested the BCR_ABL-1 activators and observed a wide
range of signal output (2- to 163-fold) that increased
with both the strength of the LZ binding domain
and the number of ZF binding sites (Figure 1B and
Supplementary Figure S2). We then compared the
activity of ZF activators generated using different DBDs
by co-transfection with the corresponding 6 Binding site
(BS) reporter (Figure 1C and Supplementary Figure S3).
A strong induction from all ZFs was observed (up to
463-fold), with HIV TFs displaying the strongest activa-
tion. No cross-reactivity was observed with activators
co-transfected with off-target reporters, demonstrating
the speciﬁcity of our ZF-TFs (Supplementary Figures S4
and S5).
The modular nature of our ZF elements allowed for the
facile construction of a set of transcriptional repressors.
These repressors can be tuned by altering the LZ dimer-
ization domain and number of target sites analogous to
our ZF activator constructs. We created 15 artiﬁcial ZF
repressors by combining ZF DBDs, the SV40 NLS and
LZs with the Kru ¨ ppel-associated Box (KRAB) transcrip-
tional repression domain (Figure 2A). To assay for repres-
sion, we generated CFP reporter constructs containing
variable numbers of copies of a 9bp ZF binding site
directly downstream of the TATA box within the CMV
promoter (Figure 2A). We ﬁrst tested BCR_ABL-1 repres-
sors and observed a signiﬁcant decrease in output signal
(2- to 9-fold), strengthening with the number of ZF
binding sites and the presence of a LZ (Figure 2B and
Supplementary Figure S6). All ZF repressors were then
tested with corresponding 6 reporters, and displayed a
similar pattern—higher levels of repression for ZF repres-
sors with a LZ domain (Figure 2C and Supplementary
Figure 1. Engineering and characterization of ZF transcriptional activators. (A) Schematic representation of the assay used to test ZF activator
function. Each transcriptional activator is expressed from the CMV promoter and tagged with a co-translationally cleaved t2a:mCherry ﬂuorescent
protein to monitor expression. ZF activator function is measured by the ability to activate the expression of 2 fused copies of cyan ﬂuorescent protein
from a reporter containing a minimal promoter and a variable number of 9bp ZF target sites. (B) Characterization of the role of leucine zipper
addition and target site copy number on ZF-TF transcriptional activation. BCR_ABL-1 activators fused to either no LZ (ZF-only), the c-Jun LZ
(Jun), or the GCN4 LZ (GCN4) were co-transfected into U-2 OS cells along with reporter plasmids containing either 2, 4 or 6 copies of the
corresponding 9bp target site. CFP reporter expression as measured by ﬂow cytometry and expressed as fold change over an off-target expression
control. (C) Functional characterization of all ZF-activators co-transfected with reporter plasmids containing 6 copies of their 9bp target sites.
5182 Nucleic Acids Research, 2012,Vol.40, No. 11Figure S7). The HIV repressors were the only exception
displaying no LZ-mediated increase. As expected, no re-
pression was seen for off-target reporters (Supplementary
Figures S8 and S9).
ZF-based Boolean logic computation
Using this set of synthetic ZF-TFs, we next sought to
construct a set of Boolean logic gates. We divided the
logic architecture into three general components: (i) a
sensory module that senses inputs and converts the
signals into ZF expression, (ii) a computational module
comprised of ZFs and corresponding response promoters
and (iii) an output module consisting of a gene encoding a
given protein.
Within this framework, we began by generating
response constructs that exhibited OR gate behavior.
OR gates were developed by utilizing hybrid promoters
consisting of various copies of binding sites for two
distinct ZF DBDs. To determine the effect of binding
site architecture on signal output, constructs containing
either 2, 4 or 6 copies of the BCR_ABL and erbB2
binding sites were generated in multiple conﬁgurations
(Figure 3A and Supplementary Figures S10 and S11).
We characterize all of our Boolean logic systems using
artiﬁcial inputs in which the CMV promoter drives expres-
sion of the computational proteins for a positive input or a
negative control protein for a negative input. Each OR
gate conﬁguration was tested by co-transfection with
either the BCR_ABL-1:GCN4 activator, the erbB2:Jun
activator or both activators in tandem. All promoter
architectures functioned as OR gates, with either a single
activator alone or both factors present together resulting
in signal output. The presence of both activators in
tandem resulted in an additional 7-fold increase in
output signal, likely due to the increased occupancy of
reporter target sites by the transcriptional activators
(Figure 3A). We also observed minor position effects,
with activator constructs having corresponding binding
sites more proximal to the TATA box displaying higher
induction (Supplementary Figures S10 and S11). The
varying outputs for different promoter architectures
allow for an additional potential layer of tunability.
A similar approach was employed using ZF repressors
to compute NOR logic. As with our OR gates, NOR gates
were generated by placing binding sites for two different
ZFs within the repressor reporter plasmids. Reporters
were constructed with either 2, 4 or 6 binding sites in
multiple conﬁgurations, and tested by transfecting with
Figure 2. Engineering and characterization of ZF transcriptional repressors. (A) Schematic representation of the assay used to test ZF repressor
function. Each transcriptional repressor is expressed from the CMV promoter and tagged with a co-translationally cleaved t2a:mCherry ﬂuorescent
protein to monitor expression. ZF repressor function is measured by the expression of 2 fused copies of cyan ﬂuorescent protein from a CMV
promoter engineered to have a variable number of 9bp ZF target sites inserted into the transcriptional start site. (B) Functional characterization of
the role of target site copy number and leucine zipper addition on ZF repressor activity. BCR_ABL-1 activators fused to either no LZ (ZF-only), the
c-Jun LZ (Jun), or the GCN4 LZ (GCN4) were co-transfected into U-2 OS cells along with reporter plasmids containing either 2, 4 or 6 copies of the
corresponding 9bp target site. The activity of each ZF repressor was determined by CFP expression measured by ﬂow cytometry and expressed as
fold change over an off-target expression control. (C) Functional characterization of all ZF-repressors co-transfected with reporter plasmids con-
taining 6 copies of their 9bp target sites.
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repressor or both repressors. All promoter architectures
functioned as NOR gates, with repression levels ranging
from 2- to 23-fold. We again observed a minor position
effect with higher levels of repression corresponding to
ZF binding site proximity to the CMV TATA box.
Thus, NOR gates can also be tuned to have different
response properties (Figure 3B and Supplementary
Figures S12 and S13).
We next sought to compute AND and NAND logic
using our transcriptional activators and repressors. To
use our split intein protein splicing strategy, we ﬁrst set
out to determine the optimal amino acid residue at which
to split our ZF-TFs. We created twelve pairs of
BCR_ABL-1:Jun activator split proteins. Each pair con-
tained an amino- (N-) and carboxy-terminal (C-) fragment
fused to the appropriate intein. These fragments were
co-transfected, either together or separately, with the 6
BCR_ABL activator reporter (Figure 4A, B and C). Fold
induction was calculated relative to CFP activation by the
C-terminal fragment alone. Five out of twelve ZF split
pairs displayed >3-fold signal output (Figure 4D and
Supplementary Figure S14). The split site between
residues 30 and 31 resulted in the highest activity,
19-fold, and was therefore chosen for further logic gate
generation. Interestingly, all functional split sites are pre-
dicted to be located in protein loop regions of the ZF,
suggesting the importance of the secondary structure on
efﬁcient protein splicing (Supplementary Figure S15).
After performing this assay we discovered that a truncated
form of the N-terminal intein fragment, intN*, lacking
four C-terminal amino acids displayed higher splicing ef-
ﬁciency, and we used this intein fragment in all further
experiments.
Next, we generated an AND gate using split
BCR_ABL-1:GCN4. Cells were transfected with each
fragment alone or both fragments together, and an
off-target ZF DBD was used as a negative control.
When both N-terminal and C-terminal fragments of
BCR_ABL-1:GCN4 activator were present, we observed
a 154-fold signal induction, a level that is comparable with
that of the parental BCR_ABL-1:GCN4 activator
(Figure 5A and Supplementary Figure S16). A NAND
gate or ‘NOT AND’ gate is the opposite of an AND
gate, returning ‘TRUE’ as long as both inputs are not
present together. To compute NAND logic, we sought
to splice together fragments of the BCR_ABL-1:GCN4
repressor. The repressor was split in the same location
as the BCR_ABL activators. We assayed for NAND
activity by co-transfection of the 6 BCR_ABL repressor
reporter with either fragment alone or both fragments
together. No repression was seen when either the
N-terminal or C-terminal fragment was transfected
alone, and when both fragments were present, a 3-fold
repression was observed (Figure 5B and Supplementary
Figure S17).
Figure 3. Engineering and characterization of ZF-based OR and NOR Boolean logic gates. In the sensory module, input signals lead to expression
of corresponding ZF-based transcription factors. In the computational module, transcription factors act on response promoters. (A) OR gate
response promoters contain target sites for two different ZF activators, and the logical operation is computed as TRUE (CFP expression) when
either one or both inputs is present. For the response data shown BCR_ABL-1:GCN4 and erbB2:Jun activators were used as ZF-1 and ZF-2,
respectively, and the response promoter contains six copies of the BCR_ABL target site upstream of 6 copies of the erbB2 target site. CFP expression
was measured by ﬂow cytometry and expressed as fold change over an off-target expression control. (B) NOR gate response promoters contain the
binding sites for two different ZF repressors, and the logical operation is computed as TRUE when neither input is present. For the response data
shown BCR_ABL-1:GCN4 and erbB2:Jun repressors were used as ZF-1 and ZF-2, respectively, and the response promoter contains six copies of the
BCR_ABL target site upstream of 6 copies of the erbB2 target site. CFP expression was measured by ﬂow cytometry and expressed as fold change
over an off-target expression control.
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We developed a large set of tunable ZF-TF computing
elements and general transcriptional framework to
perform Boolean logic operations in mammalian cells.
ZF-TFs present a scalable alternative to common syn-
thetic biology transcriptional regulators such as LacI,
Gal4 and TetR with >100 ZF DBDs that target
mutually orthogonal DNA sequences available (7,8). We
created activators and repressors using ﬁve previously de-
veloped ZF DBDs that target three orthogonal 9bp DNA
sequences and corresponding response promoters. As
these ZF DBDs are highly similar in structure to other
artiﬁcial ZF DBDs, it is likely that these too can be
readily integrated into our system architectures. In order
to generate system components that interrogate signals of
different strengths and yield responses of different
strengths, we developed methods to tune ZF-TFs. We
employed two general strategies borrowed from naturally
occurring systems: fusing ZF-TFs to LZ homo-
dimerization domains and altering the number of ZF
binding sites in response promoters. We created a large
set of parts and elucidated general design rules based on
the behaviors of these parts. Activators displayed an
increase in activity correlating with both the number of
promoter binding sites and the strength of the LZ inter-
action domain. The repressors behaved similarly display-
ing an increase in repression corresponding to the number
of binding sites and the presence of a LZ. Whereas the
strength of the LZ domain did not impact the repression
levels, this could be the result of weaker repressors
reaching a maximum repression level for the transient
transfection repressor assay. Both tuning methods could
be employed together to obtain maximum ZF-TF activity
levels. The identity of the ZF DBD also affected ZF-TF
activity, potentially due to differences in DNA binding
strength or subtle differences in ZF-TF expression levels.
This element provides yet another way to tune ZF-TF.
Whereas the precise mechanism of LZ-enhanced ZF-TF
activity is unclear, we speculate that it could be the
result of cooperative transcription factor binding or
LZ-mediated recruitment of additional ZF-TFs to the
promoter region. Both mechanisms would lead to
increased promoter occupancy by the ZF-TFs and a cor-
responding increase in activity.
To integrate signals for logic computations, we
employed hybrid promoter and novel split intein protein
splicing integration architectures. We observed strong
ON/OFF ratios for idealized CMV-expressed inputs for
OR, NOR, AND and NAND gates. The hybrid promoter
strategy used for OR and NOR computations effectively
integrated ZF-TF signals and showed tunability depend-
ent on ZF binding site number and LZ strength. Whereas
all inductions were high, the OR gate behavior was
somewhat analog as the presence of two inputs showed
Figure 4. Determining the optimal ZF-TF split site. (A) Schematic representation of the plasmids used to test for split ZF activator function. Each
ZF-N:int-N or Int-C:ZF-C fragment is expressed from a CMV expression plasmid. Activity is measured by the ability of each fragment pair to
activate a cyan ﬂuorescent protein reporter containing 6 copies of 9bp ZF target sites versus activation by the Int-C:ZF-C fragment alone.
(B) Schematic of the ZF-TF reconstitution process. After expression, the two split ZF-intein fragments bind together and undergo protein
splicing to cleave away intein fragments and reconstitute the full ZF activator leading to activation of the BCR_ABL reporter. (C) BCR_ABL-1
amino acid sequence labeled with the 12 split sites assayed. (D) Characterization of the 12 ZF-intein activator pairs assayed by transient transfection
in U-2 OS cells. CFP reporter expression was measured by ﬂow cytometry and reported as total CFP expression. Fold changes in total CFP are listed
for the activation of each split pair compared with activation by the corresponding Int-C:ZF-C fragment alone.
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Interestingly, this result suggests that the individual
ZF-TF response promoters could perhaps be further
enhanced by the addition of more ZF binding sites
beyond the 6 BS systems we report in Figure 1. The
position of the ZF binding sites also affected OR gate
activity with higher activation levels observed from
ZF-TFs with binding sites closer to the TATA Box. The
NOR gates showed comparable repression levels for single
and double inputs but also displayed a position effect with
stronger repression levels observed for ZF binding sites
located directly on the putative transcription start sites.
To compute AND and NAND logic we combined split
intein protein splicing with our ZF-TF components.
Protein splicing provides a novel method to efﬁciently
combine signals that has the advantage of generating
fully formed transcription factors. We ﬁrst found the
optimal split site for the ZF-TF activators among 12
putative split sites assayed. Interestingly, 7 out of 12
split sites were successful at activating reporter function
>3-fold demonstrating the modularity of the split inteins.
All successful split sites were located in protein loop
regions suggesting the importance of secondary structure
on splicing efﬁciency. The most efﬁcient split site showed
activity levels matching that of the complete factor. As the
split sites are located within the constant region of the
BCR_ABL-1 ZF DBD it is likely they can be used in
ZF-TFs containing different ZF DBDs. Finally, the
optimal ZF split site was effective in the context of ZF
activators with different LZ domains and also in the con-
text of a repressor to perform NAND logic. The NAND
gate showed around a 3-fold repression of the reporter.
Whereas signiﬁcantly lower than the complete factor
(9-fold repression), this is possibly due to a delay caused
by intein splicing that leads to expression from the CMV
promoter before it can be efﬁciently repressed.
Together these system components greatly expand the
repertoire of parts and devices available to mammalian
synthetic biologists. The tuning methods were effective
at generating a large variation in ZF-TF activities and
could potentially be generalized to tune other transcrip-
tion factors. While the reported systems can stand on their
own, the parts and architectures could also be used in
conjunction with other existing logic computational
methods that rely on the use of synthetic transcription
factors. While we characterize our systems using the tran-
sient transfection format, we expect that they should also
function in the context of stable cell lines with qualita-
tively similar system behaviors. The logic framework de-
veloped utilizing these factors provides a powerful new
and general method for computing Boolean logic in mam-
malian cells. Through the use of modular ZF DBDs and
Figure 5. Engineering and characterization of ZF-based AND and NAND Boolean logic gates. In the sensory module, the presence of an input
signal leads to the expression of the corresponding ZF-TF:split intein fragment, either ZF-N:Int-N or Int-C:ZF-C. In the computation module
splicing of ZF:intein fragments leads to production of a complete ZF-TF that acts upon its cognate promoter. (A) For AND gates, a ZF activator is
spliced and the logical operation is computed as TRUE only when both input signals are present. For the response data shown BCR_ABL-1:GCN4
activator split fragments were used and the response promoter contains 6 copies of the BCR_ABL target site. CFP expression was measured by ﬂow
cytometry and expressed as fold change over an off-target expression control. (B) For NAND gates, the computational module splices a ZF
repressor, and the logical operation is computed as TRUE as long as both inputs are not present together. For the response data shown
BCR_ABL-1:GCN4 repressor split fragments were used and the response promoter contains 6 copies of the BCR_ABL target site. CFP expression
was measured by ﬂow cytometry and expressed as fold change over an off-target expression control.
5186 Nucleic Acids Research, 2012,Vol.40, No. 11LZ dimerization domains, we have developed an approach
that should be readily scalable to different input/output
requirements and tolerances. Components in the system,
while orthogonal in speciﬁcity, share common structural
and functional qualities, promising to make optimization
of networks more streamlined and different networks
more comparable. The potential modularity of cellular
inputs and the tunability of output response within this
framework lends itself to the processing of multiple
cellular signals and the future rewiring of intrinsic
network topologies to engineer precise biological re-
sponses. We envision using these system components to
interrogate endogenous transcriptional inputs that are
markers for cell type, cell state and other environmental
stimuli. Future scaling up of these systems can follow our
elucidated design principles and take advantage of the
many additional LZs, ZF DBDs and split inteins
available.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Tables 1–4, Supplementary Figures 1–17
and Supplementary References [22,23].
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